All Stories

  1. Systemic Protein Biomarkers, Composite Blood Inflammatory Indices and Cellular Ratios in Metastatic Colorectal Cancer: Potential Therapeutic Targets
  2. Humoral and cellular immunogenicity of COVID-19 vaccine boosters in participants with advanced HIV disease
  3. The Effects of In Utero HIV and Antiretroviral Therapy Exposure on Infant T‐Cell and Monocyte Activation, Function, and Regulation of Immune‐Modulatory Pathways
  4. A Pilot Study on the Potential Pathological Link Between Oxidative Stress Markers and Renal Function in People Living with HIV
  5. Immunopathogenesis and Therapeutic Implications in Basal Cell Carcinoma: Current Concepts and Future Directions
  6. Sustained Activation of Myeloperoxidase Is Associated with Oxidative Stress and Inflammation in People Living with the Human Immunodeficiency Virus at Risk of Cardiovascular Disease
  7. Current and Emerging Insights into the Causes, Immunopathogenesis, and Treatment of Cutaneous Squamous Cell Carcinoma
  8. Vascular endothelial growth factor A: friend or foe in the pathogenesis of HIV and SARS-CoV-2 infections?
  9. Sodium, Potassium-Adenosine Triphosphatase as a Potential Target of the Anti-Tuberculosis Agents, Clofazimine and Bedaquiline
  10. T-Cell Phenotypes and Systemic Cytokine Profiles of People Living with HIV Admitted to Hospital with COVID-19
  11. Sodium, Potassium Adenosine Triphosphatase as a Potential Target of the Anti-Tuberculosis Agents, Clofazimine and Bedaquiline
  12. Comparative Effects of Efavirenz and Dolutegravir on Metabolomic and Inflammatory Profiles, and Platelet Activation of People Living with HIV: A Pilot Study
  13. Aberrant innate immune profile associated with COVID-19 mortality in Pretoria, South Africa
  14. Persistently Elevated Expression of Systemic, Soluble Co-Inhibitory Immune Checkpoint Molecules in People Living with HIV before and One Year after Antiretroviral Therapy
  15. Relationships of emerging biomarkers of cancer cachexia with quality of life, appetite, and cachexia
  16. Transforming growth factor-β1 and soluble co-inhibitory immune checkpoints as putative drivers of immune suppression in patients with basal cell carcinoma
  17. Emerging markers of cancer cachexia and their relationship to sarcopenia
  18. Comparison of platelet-and endothelial-associated biomarkers of disease activity in people hospitalized with Covid-19 with and without HIV co-infection
  19. Pro-Tumorigenic and Thrombotic Activities of Platelets in Lung Cancer
  20. Biomarkers for disease progression identified in psoriasis patients: A pilot study
  21. Dysregulation of systemic soluble immune checkpoints in early breast cancer is attenuated following administration of neoadjuvant chemotherapy and is associated with recovery of CD27, CD28, CD40, CD80, ICOS and GITR and substantially increased levels o...
  22. Immune and Metabolic Alterations in Children with Perinatal HIV Exposure
  23. Pro-Inflammatory Interactions of Dolutegravir with Human Neutrophils in an In Vitro Study
  24. Assessment of the efficacy of clofazimine alone and in combination with primary agents against Mycobacterium tuberculosis in vitro
  25. Systemic Immune Dysregulation in Early Breast Cancer Is Associated With Decreased Plasma Levels of Both Soluble Co-Inhibitory and Co-Stimulatory Immune Checkpoint Molecules
  26. Systemic levels of the soluble co-inhibitory immune checkpoints, CTLA-4, LAG-3, PD-1/PD-L1 and TIM-3 are markedly increased in basal cell carcinoma
  27. Elevated Levels of Soluble CTLA-4, PD-1, PD-L1, LAG-3 and TIM-3 and Systemic Inflammatory Stress as Potential Contributors to Immune Suppression and Generalized Tumorigenesis in a Cohort of South African Xeroderma Pigmentosum Patients
  28. Evaluation of three different laboratory methods to detect preformed human leukocyte antigen antibodies in a South African kidney transplant population
  29. Human immunodeficiency virus infection is associated with a differential increase in cytokine response and increased risk of perforation in acute appendicitis
  30. Interactions of HIV and Antiretroviral Therapy With Neutrophils and Platelets
  31. Submission for Special Issue: The Role of Platelet Activation in the Pathophysiology of HIV, Tuberculosis, and Pneumococcal Disease. Bedaquiline Suppresses ADP-Mediated Activation of Human Platelets In Vitro via Interference With Phosphatidylinositol 3...
  32. Differential Responsiveness of the Platelet Biomarkers, Systemic CD40 Ligand, CD62P, and Platelet-Derived Growth Factor-BB, to Virally-Suppressive Antiretroviral Therapy
  33. Plasma Inflammatory Biomarkers Predict CD4+ T-cell Recovery and Viral Rebound in HIV-1 Infected Africans on Suppressive Antiretroviral Therapy
  34. ADP-Mediated Upregulation of Expression of CD62P on Human Platelets Is Critically Dependent on Co-Activation of P2Y1 and P2Y12 Receptors
  35. Contrasting Immunopathogenic and Therapeutic Roles of Granulocyte Colony-Stimulating Factor in Cancer
  36. High Mobility Group Box 1 in Human Cancer
  37. Role of the Neutrophil in the Pathogenesis of Advanced Cancer and Impaired Responsiveness to Therapy
  38. Biofilm formation and induction of stress response genes is a common response of several serotypes of the pneumococcus to cigarette smoke condensate
  39. Cigarette smoke exposure induces expression of the pneumococcal <i>erm</i>(B) macrolide resistance gene
  40. What could be the source of endotoxin that plays a role in the development of rheumatoid arthritis?
  41. Interleukin-10 and interleukin-1 receptor antagonist distinguish between patients with sepsis and the systemic inflammatory response syndrome (SIRS)
  42. Plasma Biomarkers of Human Immunodeficiency Virus–Related Systemic Inflammation and Immune Activation in Sub-Saharan Africa Before and During Suppressive Antiretroviral Therapy
  43. Effects of Tobacco Usage and Antiretroviral Therapy on Biomarkers of Systemic Immune Activation in HIV-Infected Participants
  44. Strategies for screening cord blood for a public cord blood bank in high HIV prevalence regions
  45. The Role of Transforming Growth Factor Beta-1 in the Progression of HIV/AIDS and Development of Non-AIDS-Defining Fibrotic Disorders
  46. Facial appearance reveals immunity in African men
  47. Investigation of the Mechanism of Anti-Inflammatory Action and Cytotoxicity of a Semipurified Fraction and Isolated Compounds From the Leaf of Peltophorum africanum (Fabaceae)
  48. HIV as a Cause of Immune Activation and Immunosenescence
  49. Systemic Immune Activation Profiles of HIV-1 Subtype C-Infected Children and Their Mothers
  50. Cord Blood Stem Cell Banking
  51. Formoterol is more effective than salmeterol in suppressing neutrophil reactivity
  52. Constituting a public umbilical cord blood bank in South Africa
  53. Expression of soluble triggering receptor expressed on myeloid cells-1 in childhood CF and non-CF bronchiectasis
  54. Investigation of biofilm formation on a charged intravenous catheter relative to that on a similar but uncharged catheter
  55. Oxidative induction of pro-inflammatory cytokine formation by human monocyte-derived macrophages following exposure to manganesein vitro
  56. Circulating Biomarkers of Immune Activation Distinguish Viral Suppression from Nonsuppression in HAART-Treated Patients with Advanced HIV-1 Subtype C Infection
  57. The Beta-2-Adrenoreceptor Agonists, Formoterol and Indacaterol, but Not Salbutamol, Effectively Suppress the Reactivity of Human NeutrophilsIn Vitro
  58. Cysteinyl Leukotriene Receptor-1 Antagonists as Modulators of Innate Immune Cell Function
  59. Can the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting?
  60. The prevalence of smoking and the knowledge of smoking hazards and smoking cessation strategies among HIV- positive patients in Johannesburg, South Africa
  61. Lack of efficacy of erythromycin in children with human immunodeficiency virus-related bronchiectasis – A randomised controlled trial
  62. Lack of Efficacy of an Immunomodulatory Macrolide in Childhood HIV Related Bronchiectasis: A Randomised, Placebo-Controlled Trial
  63. Overview of Community-Acquired Pneumonia and the Role of Inflammatory Mechanisms in the Immunopathogenesis of Severe Pneumococcal Disease
  64. Manganese promotes increased formation of hydrogen peroxide by activated human macrophages and neutrophilsin vitro
  65. Effects of cigarette smoke condensate on pneumococcal biofilm formation and pneumolysin
  66. Pathogen- and Host-Directed Anti-Inflammatory Activities of Macrolide Antibiotics
  67. Characterization of the interactions of the pneumolysoid, Δ6 PLY, with human neutrophils in vitro
  68. Clofazimine: current status and future prospects
  69. Calcium-dependent potentiation of the pro-inflammatory functions of human neutrophils by tigecycline in vitro
  70. Interactive inhibitory effects of formoterol and montelukast on activated human neutrophils
  71. Posaconazole attenuates leukotriene B4 release and uptake of calcium by chemoattractant-activated human neutrophils: a potential strategy to control neutrophil-mediated inflammation
  72. Leukotrienes C4 and D4 sensitize human neutrophils for hyperreactivity to chemoattractants
  73. Protein kinase C promotes restoration of calcium homeostasis to platelet activating factor-stimulated human neutrophils by inhibition of phospholipase C
  74. Montelukast inhibits neutrophil pro‐inflammatory activity by a cyclic AMP‐dependent mechanism
  75. Comparison of the Anti‐inflammatory Activities of Imidazole Antimycotics in Relation to Molecular Structure
  76. Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro
  77. Itraconazole-mediated inhibition of calcium entry into platelet-activating factor-stimulated human neutrophils is due to interference with production of leukotriene B4
  78. Changes in serum cytokines after repeated bouts of downhill running
  79. Clarithromycin alone and in combination with ceftriaxone inhibits the production of pneumolysin by both macrolide-susceptible and macrolide-resistant strains of Streptococcus pneumoniae
  80. Vanadium promotes hydroxyl radical formation by activated human neutrophils
  81. Effects of clofazimine on potassium uptake by a Trk-deletion mutant of Mycobacterium tuberculosis
  82. Inositol 1,4,5-triphosphate-mediated shuttling between intracellular stores and the cytosol contributes to the sustained elevation in cytosolic calcium in FMLP-activated human neutrophils
  83. Taming the neutrophil: calcium clearance and influx mechanisms as novel targets for pharmacological control
  84. Pneumolysin-mediated activation of NFκB in human neutrophils is antagonized by docosahexaenoic acid
  85. Investigation into the relationship between calyculin A-mediated potentiation of NADPH oxidase activity and inhibition of store-operated uptake of calcium by human neutrophils
  86. Antimicrobial activity of clofazimine is not dependent on mycobacterial C-type phospholipases
  87. Itraconazole antagonizes store-operated influx of calcium into chemoattractant-activated human neutrophils
  88. Endogenous adenosine regulates neutrophil pro-inflammatory activities by cyclic AMP-dependent accelerated clearance of cytosolic calcium
  89. Dissociation of the PAF‐receptor from NADPH oxidase and adenylate cyclase in human neutrophils results in accelerated influx and delayed clearance of cytosolic calcium
  90. Platelet‐activating factor and lyso‐PAF possess direct antimicrobial properties in vitro
  91. Vitamin E attenuates the injurious effects of bioactive phospholipids on human ciliated epitheliumin vitro
  92. Pneumolysin Potentiates Production of Prostaglandin E2 and Leukotriene B4 by Human Neutrophils
  93. Proinflammatory Interactions of Pneumolysin with Human Neutrophils
  94. Accelerated calcium influx and hyperactivation of neutrophils in chronic granulomatous disease
  95. Antimycobacterial action of B4128, a novel tetramethylpiperidyl-substituted phenazine
  96. Inhibition of potassium transport and growth of mycobacteria exposed to clofazimine and B669 is associated with a calcium-independent increase in microbial phospholipase A2 activity
  97. The riminophenazines, clofazimine and B669, inhibit potassium transport in Gram-positive bacteria by a lysophospholipid-dependent mechanism